Pharmaceutical Industry: Organization of the Pricing and Market Access Function

Published on January 19, 2023

Success factors for organizational set-up, operational effectiveness, and talent management, including specifics for German affiliates. As the pharmaceutical industry faces price pressure and a challenging payer environment, realizing the full value of a drug becomes an ever more challenging endeavour. In order to succeed in this environment, pharmaceutical executives and managers are looking to shape effective and efficient organizations. Read in this blog-article about the optimal organization of the Pricing and Market Access (P&MA) function. 

The Pricing and Market Access (P&MA) function plays a critical role throughout a drug’s lifecycle. During clinical development, P&MA input is crucial for prioritizing drugs which deliver the highest value and for shaping clinical trials based on payer requirements. From early development to beyond loss of exclusivity, the P&MA function supports optimal pricing and market access which lay the…